Correlation Between Pieris Pharmaceuticals and Alzamend Neuro

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Alzamend Neuro at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Alzamend Neuro into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pieris Pharmaceuticals and Alzamend Neuro, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Alzamend Neuro and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Alzamend Neuro. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Alzamend Neuro.

Diversification Opportunities for Pieris Pharmaceuticals and Alzamend Neuro

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pieris and Alzamend is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Alzamend Neuro in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alzamend Neuro and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Alzamend Neuro. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alzamend Neuro has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Alzamend Neuro go up and down completely randomly.

Pair Corralation between Pieris Pharmaceuticals and Alzamend Neuro

Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to generate 0.56 times more return on investment than Alzamend Neuro. However, Pieris Pharmaceuticals is 1.78 times less risky than Alzamend Neuro. It trades about -0.12 of its potential returns per unit of risk. Alzamend Neuro is currently generating about -0.21 per unit of risk. If you would invest  1,725  in Pieris Pharmaceuticals on September 1, 2024 and sell it today you would lose (100.00) from holding Pieris Pharmaceuticals or give up 5.8% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pieris Pharmaceuticals  vs.  Alzamend Neuro

 Performance 
       Timeline  
Pieris Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pieris Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Pieris Pharmaceuticals is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Alzamend Neuro 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alzamend Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pieris Pharmaceuticals and Alzamend Neuro Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pieris Pharmaceuticals and Alzamend Neuro

The main advantage of trading using opposite Pieris Pharmaceuticals and Alzamend Neuro positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Alzamend Neuro can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alzamend Neuro will offset losses from the drop in Alzamend Neuro's long position.
The idea behind Pieris Pharmaceuticals and Alzamend Neuro pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments